Fecal Calprotectin Correlates More Closely With the Simple Endoscopic Score for Crohn's Disease (SES-CD) than CRP, Blood Leukocytes, and the CDAI
- 1 January 2010
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in The American Journal of Gastroenterology
- Vol. 105 (1), 162-169
- https://doi.org/10.1038/ajg.2009.545
Abstract
OBJECTIVES: METHODS: RESULTS: CONCLUSIONS:Keywords
This publication has 31 references indexed in Scilit:
- Diagnostics of Inflammatory Bowel DiseaseGastroenterology, 2007
- Accuracy of Four Fecal Assays in the Diagnosis of ColitisDiseases of the Colon & Rectum, 2007
- Scheduled maintenance treatment with infliximab is superior to episodic treatment for the healing of mucosal ulceration associated with Crohn's diseaseGastrointestinal Endoscopy, 2006
- Human Anti–Tumor Necrosis Factor Monoclonal Antibody (Adalimumab) in Crohn’s Disease: the CLASSIC-I TrialGastroenterology, 2006
- Polymorphisms within the C-Reactive Protein (CRP) Promoter Region Are Associated with Plasma CRP LevelsAmerican Journal of Human Genetics, 2005
- Infliximab use in Crohn’s diseaseExpert Opinion on Biological Therapy, 2005
- Normalization of faecal calprotectin: a predictor of mucosal healing in patients with inflammatory bowel diseaseScandinavian Journal of Gastroenterology, 2004
- Crohn's disease: monitoring disease activityAlimentary Pharmacology & Therapeutics, 2003
- Maintenance infliximab for Crohn's disease: the ACCENT I randomised trialThe Lancet, 2002
- Peripheral blood monocyte cytokine production and acute phase response in inflammatory bowel disease.Gut, 1992